1,7-phenanthroline has been researched along with Encephalopathy, Toxic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alharrasi, A; Ashraf, GM; Damanhouri, GA; Hadi, SM; Khan, HY; Perveen, A; Tabrez, S | 1 |
Chen, XG; Li, HY; Liu, ZJ; Lv, HN; Si, YK; Su, FQ; Yu, SS; Zhang, HJ; Zhang, Y | 1 |
2 other study(ies) available for 1,7-phenanthroline and Encephalopathy, Toxic
Article | Year |
---|---|
Pro-oxidant DNA breakage induced by the interaction of L-DOPA with Cu(II): a putative mechanism of neurotoxicity.
Topics: Antiparkinson Agents; Chelating Agents; Comet Assay; Copper; DNA Breaks; Humans; Hydroxyl Radical; Levodopa; Lymphocytes; Neurotoxicity Syndromes; Oxidation-Reduction; Phenanthrolines; Reactive Oxygen Species; Superoxides | 2015 |
Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Indolizines; Mice; Neurotoxicity Syndromes; Nucleic Acids; PC12 Cells; Phenanthrenes; Phenanthrolines; Plant Roots; Rats; Transplantation, Heterologous; Tylophora; Vinblastine | 2011 |